Billions of sea stars — victims of a deadly wasting illness — have perished over the last decade, imperiling marine ...

Dr Jeannine Hess examined how antimicrobial resistance already imposes a vast global death toll, why the antibiotic development pipeline has weakened and how her lab’s light-activated metal ...

In recent years, everyday objects — from wallets to travel gear and wearable tech — have become thinner, softer, and more ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Offsetting the developmental challenge is a major commercial triumph secured in December. The aerospace firm won an $816 million contract from the U.S. Space Development Agency (SDA) to design and ...

Biogen is transitioning from a shrinking MS franchise to a portfolio anchored in rare disease and Alzheimer’s therapies, driving improved mix quality. Learn more about BIIB stock here.

That's the audience that the London Business School is targeting with a new one-year MBA program. Unlike a traditional ...

Most of us are fortunate enough to associate being in a coma with something we’ve only seen on TV or in movies. It looks terrifying, and it’s something you wouldn’t wish on your worst enemy. But sadly ...